Trial Information
A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab Monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting
Sponsor: AbbVie
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
